SecBot SecBot
SECBOTREPLAY Home › Report › FATE

FATE · Two insiders at Fate Therapeutics, including the CEO, sold a combined…

FATE THERAPEUTICS INC · CLUSTER filed Aug 5, 2026 at 16:01 ET

At the news

BEARISHIMPACT 5/10

CLUSTER filed Aug 5, 2026 at 16:01 ET

Two insiders at Fate Therapeutics, including the CEO, sold a combined $204K worth of shares in open-market transactions on August 4, 2026. While the dollar amount is modest relative to the $303M market cap, multi-executive selling at a struggling biotech with a weak historical follow-through on our calls warrants caution.

  • Two insiders sold a total of 82,747 shares for $204,506 in open-market transactions on Aug 4, 2026.
  • President & CEO Bahram Valamehr sold 43,947 shares for $108K; board member Cindy Tahl sold 38,800 shares for $95K.
  • This is a cluster of C-suite + board sells, suppressing the typical informational signal of insider sales.
  • The total sale value of $204K represents ~0.07% of the $303M market cap, below the 0.1% materiality threshold.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access